Literature DB >> 2669198

Induction of stable chimerism and elimination of graft-versus-host disease by depletion of T lymphocytes from bone marrow using immunomagnetic beads.

A L Hoffman1, L Makowka, D V Cramer, X Cai, B Banner, A Pascualone, S Hoffmann, T E Starzl.   

Abstract

The goal of transplantation is the induction of immunologic tolerance. At present, nonspecific immunosuppression is used to prevent graft rejection and, commonly, graft-versus-host disease (GVHD). Nevertheless, nonspecific immunosuppressive therapy is frequently complicated by infection, malignant tumors, and drug toxicity. In order to examine whether hematopoietic chimerism can be used to induce specific allograft tolerance, we have reconstituted lethally irradiated Lewis rats with ACI bone marrow that has been depleted of T cells with use of immunomagnetic beads. This technique consists of binding OX-19, a mouse anti-rat pan-T lymphocyte monoclonal antibody, to magnetic polymer beads. Mixing of bone marrow or splenocytes with the bead/OX-19 complexes, followed by magnetic separation, results in significant depletion of T cells with minimal nonspecific cell loss. Immunomagnetic T-cell depletion of bone marrow, followed by reconstitution of a lethally irradiated host, allows for the development of stable, mixed hematopoietic chimerae without evidence of GVHD. These hosts are immunocompetent by clinical criteria. Recipients of untreated donor bone marrow that did or did not receive nonspecific immunosuppression demonstrated varying degrees of GVHD and reduced survival. The ability to rapidly and simply deplete T lymphocytes from bone marrow and produce stable, immunocompetent hematopoietic chimerae without GVHD may be an important method for tolerance induction to vascularized allografts.

Entities:  

Mesh:

Year:  1989        PMID: 2669198      PMCID: PMC2967215     

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  19 in total

1.  Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).

Authors:  S T Ildstad; S M Wren; J A Bluestone; S A Barbieri; D Stephany; D H Sachs
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

2.  Magnetic monosized polymer particles for fast and specific fractionation of human mononuclear cells.

Authors:  T Lea; F Vartdal; C Davies; J Ugelstad
Journal:  Scand J Immunol       Date:  1985-08       Impact factor: 3.487

3.  The roles of host and donor cells in the rejection of skin allografts by T cell-deprived rats injected with syngeneic T cells.

Authors:  M J Dallman; D W Mason; M Webb
Journal:  Eur J Immunol       Date:  1982-06       Impact factor: 5.532

Review 4.  The pathology of bone marrow transplantation.

Authors:  R E Slavin; J M Woodruff
Journal:  Pathol Annu       Date:  1974

5.  Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres.

Authors:  J G Treleaven; F M Gibson; J Ugelstad; A Rembaum; T Philip; G D Caine; J T Kemshead
Journal:  Lancet       Date:  1984-01-14       Impact factor: 79.321

6.  Immunomagnetic T-lymphocyte depletion (ITLD) of rat bone marrow using OX-19 monoclonal antibody.

Authors:  A L Hoffman; L Makowka; D V Cramer; X Cai; A Pascualone; B F Banner; D G Sheahan; P Rettinger; T E Starzl
Journal:  J Invest Surg       Date:  1989       Impact factor: 2.533

7.  The genetics of bone marrow transplantation in the rat.

Authors:  M K Oaks; D V Cramer
Journal:  Transplantation       Date:  1985-01       Impact factor: 4.939

8.  Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance.

Authors:  S T Ildstad; S M Wren; J A Bluestone; S A Barbieri; D H Sachs
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

9.  Sequential morphology of graft-versus-host disease in the rat radiation chimera.

Authors:  W E Beschorner; P J Tutschka; G W Santos
Journal:  Clin Immunol Immunopathol       Date:  1982-02

10.  In vivo and in vitro characterization of specific hyporeactivity to skin xenografts in mixed xenogeneically reconstituted mice (B10 + F344 rat----B10).

Authors:  S T Ildstad; S M Wren; S O Sharrow; D Stephany; D H Sachs
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

View more
  4 in total

1.  The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease.

Authors:  A L Hoffman; L Makowka; B Banner; X Cai; D V Cramer; A Pascualone; S Todo; T E Starzl
Journal:  Transplantation       Date:  1990-03       Impact factor: 4.939

2.  Simultaneous administration of a low-dose mixture of donor bone marrow cells and splenocytes plus adenovirus containing the CTLA4Ig gene result in stable mixed chimerism and long-term survival of cardiac allograft in rats.

Authors:  Yongzhu Jin; Qingyin Zhang; Jie Hao; Xiang Gao; Yinglu Guo; Shusheng Xie
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

3.  The Positive Impact of Donor Bone Marrow Cells Transplantation into Immunoprivileged Compartments on the Survival of Vascularized Skin Allografts.

Authors:  Arkadiusz Jundziłł; Aleksandra Klimczak; Erhan Sonmez; Grzegorz Brzezicki; Maria Siemionow
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-10-11       Impact factor: 4.291

4.  Microglial Function Is Distinct in Different Anatomical Locations during Retinal Homeostasis and Degeneration.

Authors:  Emily G O'Koren; Chen Yu; Mikael Klingeborn; Alicia Y W Wong; Cameron L Prigge; Rose Mathew; Joan Kalnitsky; Rasha A Msallam; Aymeric Silvin; Jeremy N Kay; Catherine Bowes Rickman; Vadim Y Arshavsky; Florent Ginhoux; Miriam Merad; Daniel R Saban
Journal:  Immunity       Date:  2019-03-05       Impact factor: 43.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.